CLINICAL_TRIALS
trial_result
· 2012-07-25
Clinical Trial Update: AZD6765 Severe Major Depressive Disorder (MDD) IV [Phase 2]
Summary
A Phase 2 clinical trial update for AZD6765 in adults with Major Depressive Disorder, which has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED